3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
3
Unknown
2
Recruiting
2
Withdrawn
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
9
Rectal Neoplasms
3
Lymphatic Metastasis
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Uterine Cervical Neoplasms
1
Secondary Lymphedema
1
Neoplasm Micrometastasis
1
Melanoma
1
Liver Neoplasms
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Diverticular Diseases
1
Digestive System Diseases
1
Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis
1
Colonic Neoplasms
1
Cervical Cancer Stage IB1
1
Carcinoma, Hepatocellular
1
Anastomotic Leak
1
Interventions
Oxaliplatin
81
S 1 (combination)
55
Capecitabine
44
apatinib
32
Paclitaxel
32
Docetaxel
32
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
Tegafur
9
Nivolumab
9
Neoadjuvant Therapy
9
pembrolizumab
8
Laparoscopy
8
Gastrectomy
8
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
tislelizumab
6
Ramucirumab
6
Gastroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Indocyanine Green
×
Clear all
NCT05229874
2023-10-19
FUTURE-01
Hebei Medical University
Phase 2
Unknown
96 enrolled
NCT05720598
2023-02-09
POLA
Medical University of Lublin
Phase NA
Unknown
190 enrolled